Home / Inspections / 1026688

FDA Inspection 1026688 — Contract Pharmacal Corporation

Contract Pharmacal Corporation — FEI 2427358

The FDA completed an inspection of Contract Pharmacal Corporation on August 15, 2017 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1167279 (VAI Thu Apr 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1036595 (NAI Wed Nov 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 994796 (NAI Fri Dec 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 978462 (NAI Thu Jun 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910031 (NAI Thu Jan 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources